Hsa_circ_0005397 promotes hepatocellular carcinoma progression through EIF4A3

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Hepatocellular carcinoma (HCC) is a major global health concern with complex progression mechanisms.
• Circular RNAs (circRNAs) are emerging as critical regulators in various cancers, including HCC.
• Understanding the role of specific circRNAs like hsa_circ_0005397 is crucial for developing targeted therapies.

Purpose of the Study:

• To investigate the expression and functional role of hsa_circ_0005397 in hepatocellular carcinoma.
• To elucidate the underlying molecular mechanism of hsa_circ_0005397 in HCC progression.
• To assess the potential of hsa_circ_0005397 as a diagnostic biomarker for HCC.

Main Methods:

• Quantitative reverse transcription-polymerase chain reaction (qRT-PCR) to measure circRNA and mRNA expression.
• Western Blot (WB) and immunohistochemistry (IHC) for protein level analysis.
• Cell proliferation, cell cycle, migration, and invasion assays to evaluate functional roles.
• RNA Binding Protein Immunoprecipitation (RIP) assays to confirm molecular interactions.

Main Results:

• Hsa_circ_0005397 was significantly upregulated in HCC tissues and cell lines, demonstrating diagnostic potential.
• Upregulation of hsa_circ_0005397 correlated with advanced tumor size and stage.
• Hsa_circ_0005397 promotes HCC cell proliferation, migration, and invasion, partly through interaction with EIF4A3.

Conclusions:

• Hsa_circ_0005397 acts as an oncogenic circRNA in HCC progression by interacting with EIF4A3.
• Targeting the hsa_circ_0005397/EIF4A3 axis may offer a novel therapeutic strategy for HCC.
• Further research into hsa_circ_0005397 could lead to valuable clinical applications in HCC management.